These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 23921611)
1. Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment. Hua L; Andersen JW; Daar ES; Glesby MJ; Hollabaugh K; Tierney C AIDS; 2013 Nov; 27(17):2725-34. PubMed ID: 23921611 [TBL] [Abstract][Full Text] [Related]
2. Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status. Marcus JL; Leyden WA; Chao CR; Xu L; Quesenberry CP; Tien PC; Klein DB; Towner WJ; Horberg MA; Silverberg MJ AIDS Patient Care STDS; 2015 Jul; 29(7):370-8. PubMed ID: 26061798 [TBL] [Abstract][Full Text] [Related]
3. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history. Cescon A; Chan K; Raboud JM; Burchell AN; Forrest JI; Klein MB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Cooper C; AIDS; 2014 Jan; 28(1):121-7. PubMed ID: 24413263 [TBL] [Abstract][Full Text] [Related]
4. Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-Registry. Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK HIV Clin Trials; 2018 Dec; 19(6):225-234. PubMed ID: 30890063 [TBL] [Abstract][Full Text] [Related]
5. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients. Portocarrero Nuñez JA; Gonzalez-Garcia J; Berenguer J; Gallego MJV; Loyarte JAI; Metola L; Bernal E; Navarro G; Del Amo J; Jarrín I; Medicine (Baltimore); 2018 Sep; 97(38):e12238. PubMed ID: 30235668 [TBL] [Abstract][Full Text] [Related]
6. Persistently low CD4 cell counts are associated with hepatic events in HCV/HIV coinfected patients: data from the national free antiretroviral treatment program of China. Lin W; Zhong H; Wen C; He Y; Zheng X; Li H; Chen X; He H; Chen J; Chen L; Liu C; Tang X; Cai W; Li L Chin Med J (Engl); 2022 Nov; 135(22):2699-2705. PubMed ID: 36574222 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia. van Griensven J; Phirum L; Choun K; Thai S; De Weggheleire A; Lynen L PLoS One; 2014; 9(2):e88552. PubMed ID: 24533106 [TBL] [Abstract][Full Text] [Related]
8. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. De Luca A; Bugarini R; Lepri AC; Puoti M; Girardi E; Antinori A; Poggio A; Pagano G; Tositti G; Cadeo G; Macor A; Toti M; D'Arminio Monforte A; Arch Intern Med; 2002 Oct; 162(18):2125-32. PubMed ID: 12374521 [TBL] [Abstract][Full Text] [Related]
9. Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals. Martinez V; Ta TD; Mokhtari Z; Guiguet M; Miailhes P; Valantin MA; Charlotte F; Bertheau P; Molina JM; Katlama C; Caumes E BMC Res Notes; 2012 Jul; 5():180. PubMed ID: 22490728 [TBL] [Abstract][Full Text] [Related]
10. HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients. Cooper C; Rollet-Kurhajec KC; Young J; Vasquez C; Tyndall M; Gill J; Pick N; Walmsley S; Klein MB; HIV Med; 2015 Jan; 16(1):24-31. PubMed ID: 24837567 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival. Chen M; Wong WW; Law MG; Kiertiburanakul S; Yunihastuti E; Merati TP; Lim PL; Chaiwarith R; Phanuphak P; Lee MP; Kumarasamy N; Saphonn V; Ditangco R; Sim BL; Nguyen KV; Pujari S; Kamarulzaman A; Zhang F; Pham TT; Choi JY; Oka S; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Chen YM PLoS One; 2016; 11(3):e0150512. PubMed ID: 26933963 [TBL] [Abstract][Full Text] [Related]
12. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication. Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C; Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361 [TBL] [Abstract][Full Text] [Related]
13. Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa. Martin NK; Devine A; Eaton JW; Miners A; Hallett TB; Foster GR; Dore GJ; Easterbrook PJ; Legood R; Vickerman P AIDS; 2014 Jan; 28 Suppl 1():S35-46. PubMed ID: 24468945 [TBL] [Abstract][Full Text] [Related]
14. Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon. Mbougua JB; Laurent C; Kouanfack C; Bourgeois A; Ciaffi L; Calmy A; Gwet H; Koulla-Shiro S; Ducos J; Mpoudi-Ngolé E; Molinari N; Delaporte E BMC Public Health; 2010 Mar; 10():105. PubMed ID: 20193053 [TBL] [Abstract][Full Text] [Related]
15. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy. Houghtaling L; Moh R; Abdou Chekaraou M; Gabillard D; Anglaret X; Eholié SP; Zoulim F; Danel C; Lacombe K; Boyd A AIDS Res Hum Retroviruses; 2018 May; 34(5):439-445. PubMed ID: 29466862 [TBL] [Abstract][Full Text] [Related]
16. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users. Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP; Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472 [TBL] [Abstract][Full Text] [Related]
17. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Idoko J; Meloni S; Muazu M; Nimzing L; Badung B; Hawkins C; Sankalé JL; Ekong E; Murphy R; Kanki P; Thio CL Clin Infect Dis; 2009 Oct; 49(8):1268-73. PubMed ID: 19772386 [TBL] [Abstract][Full Text] [Related]
18. Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study. Focà E; Fabbiani M; Prosperi M; Quiros Roldan E; Castelli F; Maggiolo F; Di Filippo E; Di Giambenedetto S; Gagliardini R; Saracino A; Di Pietro M; Gori A; Sighinolfi L; Pan A; Postorino MC; Torti C; Medicine (Baltimore); 2016 Jul; 95(29):e4091. PubMed ID: 27442636 [TBL] [Abstract][Full Text] [Related]
19. Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1/HCV coinfected patients undergoing highly active antiretroviral therapy. Kang F; Chen W; Zhang X; Nie W; Fu J; Xu X; Zhao P; Zhang X; Li W; Wang FS; Zhang Z; Zhao M J Acquir Immune Defic Syndr; 2013 Feb; 62(2):135-42. PubMed ID: 23075912 [TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients. Balagopal A; Kandathil AJ; Higgins YH; Wood J; Richer J; Quinn J; Eldred L; Li Z; Ray SC; Sulkowski MS; Thomas DL Hepatology; 2014 Aug; 60(2):477-86. PubMed ID: 24706559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]